Silver Book Fact

Fact image

Average direct medical costs over time, in 2001, for 194 participants in a community-based pharmaceutical care services program for patients with diabetes.

Cranor, Carole W., Barry A. Bunting, and Dale B. Christensen. The Asheville Project: Long-Term Clinical and Economic Outcomes of a Community Pharmacy Diabetes Care Program. J Am Pharm Assoc. 2003; 43(2): 173-84. http://www.ncbi.nlm.nih.gov/pubmed/12688435

Reference

Title
The Asheville Project: Long-Term Clinical and Economic Outcomes of a Community Pharmacy Diabetes Care Program
Publication
J Am Pharm Assoc
Publication Date
2003
Authors
Cranor, Carole W., Barry A. Bunting, and Dale B. Christensen
Volume & Issue
Volume 43, Issue 2
Pages
173-84
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • DR Treatment Savings in the US
    Every year, the U.S. saves an estimated $1.6 billion by treating DR.  
  • For every 10 mmHg reduction in systolic blood pressure, the risk of diabetic complications is reduced by 12%.  
  • 150 drugs are in development for diabetes. Diabetes affects 12.2 million Americans age 60 and older.  
  • Improved control of cholesterol or blood lipids, can reduce diabetic complications by 20-50%.  
  • Every additional dollar spent on statin therapy for diabetes patients without cardiovascular disease has produced health gains valued between $7 and $31.